Page last updated: 2024-11-13

1,25(oh)2-16-ene-23-yne-26,27-hexafluoro-19-nor-d3

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

The chemical name you provided, **1,25(OH)2-16-ene-23-yne-26,27-hexafluoro-19-nor-D3**, describes a complex and highly modified steroid molecule. Let's break down its components:

* **1,25(OH)2:** This indicates that the molecule has hydroxyl groups (OH) attached at the 1st and 25th carbon positions. This is characteristic of **vitamin D3**, which is essential for calcium absorption and bone health.
* **16-ene:** The presence of a double bond at the 16th carbon position.
* **23-yne:** This denotes a triple bond at the 23rd carbon position.
* **26,27-hexafluoro:** The 26th and 27th carbon positions have six fluorine atoms attached.
* **19-nor:** This indicates that the 19th carbon atom is missing, making it a nor derivative.
* **D3:** This signifies that the molecule is a derivative of vitamin D3, also known as cholecalciferol.

**In summary, this complex molecule is a highly modified vitamin D3 analog with several structural alterations, including double and triple bonds, fluorine substitutions, and a missing carbon atom.**

**Why is it important for research?**

Modified vitamin D3 analogs are extensively researched for their potential therapeutic applications due to their unique properties. They may exhibit:

* **Increased potency:** Certain modifications can enhance the molecule's activity, making it more effective at its target receptors.
* **Improved bioavailability:** Changes in the molecule's structure can improve its absorption and distribution in the body.
* **Longer half-life:** Some modifications can increase the time the molecule stays active in the body, leading to more sustained effects.
* **Selective activity:** Specific modifications can target certain receptors or tissues, potentially minimizing unwanted side effects.

**This particular molecule, with its unusual combination of modifications, could be investigated for its potential in treating various conditions, including:**

* **Bone diseases:** Vitamin D3 is crucial for bone health, and analogs with improved activity could be beneficial for osteoporosis and other bone disorders.
* **Autoimmune diseases:** Vitamin D3 analogs have shown promise in modulating immune responses, potentially making them useful in managing autoimmune conditions like rheumatoid arthritis.
* **Cancer:** Some vitamin D3 analogs have demonstrated anticancer activity, warranting further investigation for their potential as anti-cancer agents.

**It's important to note that this specific molecule's research history and potential applications are not readily available without further information or specific scientific publications.** However, the structural features of this complex molecule suggest its potential for investigation in the context of vitamin D3 research and development.

1,25(OH)2-16-ene-23-yne-26,27-hexafluoro-19-nor-D3: a vitamin D analog; Ro 26-2198 is the (23Z)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID73014114
MeSH IDM0362721

Synonyms (6)

Synonym
(oh)2-ene-yne-(f)6-d3
ro 26-2198
1,25(oh)2-16-ene-23-yne-26,27-hexafluoro-19-nor-d3
bxl 698
bxl 219
195527-19-6
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.03 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]